Benzinga's Top Upgrades, Downgrades For May 7, 2019

Top Upgrades

  • JMP Securities upgraded Solaredge Technologies Inc SEDG from Market Underperform to Market Outperform. SolarEdge Technologies shares rose 18 percent to $51.80 in pre-market trading.
  • Analysts at Benchmark upgraded Veeco Instruments Inc. VECO from Hold to Buy. Veeco Instruments shares fell 0.1 percent to $12.96 in pre-market trading.
  • Baird upgraded Duluth Holdings Inc DLTH from Neutral to Outperform. Duluth Holdings rose 1.8 percent to $16.90 in pre-market trading.
  • Analysts at Oppenheimer upgraded GW Pharmaceuticals PLC- ADR GWPH from Perform to Outperform. GW Pharmaceuticals rose 8.3 percent to $195.00 in pre-market trading.
  • Berenberg upgraded CyrusOne Inc CONE from Hold to Buy. CyrusOne shares fell 0.65 percent to close at $60.71 on Monday.
  • Longbow Research upgraded Texas Roadhouse Inc TXRH from Neutral to Buy. Texas Roadhouse rose 0.6 percent to $55.26 in pre-market trading.
  • Stifel Nicolaus upgraded Cohu, Inc. COHU from Hold to Buy. Cohu shares rose 4.5 percent to $16.16 in pre-market trading.
  • Analysts at Wells Fargo upgraded Computer Programs & Systems, Inc. CPSI from Market Perform to Outperform. Computer Programs shares gained 4.51 percent to close at $28.05 on Monday.
  • Macquarie upgraded Planet Fitness Inc PLNT from Neutral to Outperform. Planet Fitness shares rose 0.9 percent to $73.78 in pre-market trading.
  • Evercore ISI Group upgraded Sinclair Broadcast Group Inc SBGI from In-Line to Outperform. Sinclair Broadcast shares rose 0.9 percent to $61.00 in pre-market trading.

 

Top Downgrades

  • Barclays downgraded Boeing Co BA from Overweight to Equal-Weight. Boeing shares fell 1.2 percent to $367.00 in pre-market trading.
  • Stifel Nicolaus downgraded Anadarko Petroleum Corporation APC from Buy to Hold. Anadarko Petroleum shares fell 0.2 percent to $75.35 in pre-market trading.
  • UBS downgraded Gardner Denver Holdings Inc GDI from Buy to Neutral. Gardner Denver shares closed at $34.10 on Monday.
  • SVB Leerink downgraded Intersect ENT Inc XENT from Outperform to Market Perform. Intersect ENT shares fell 22.3 percent to $25.75 in pre-market trading.
  • Wells Fargo downgraded Wageworks Inc WAGE from Outperform to Market Perform. WageWorks shares rose 0.36 percent to close at $50.00 on Monday.
  • Goldman Sachs downgraded Fluor Corporation (NEW) FLR from Buy to Neutral. Fluor shares fell 2 percent to $28.43 in pre-market trading.
  • SVB Leerink downgraded Adaptimmune Therapeutics PLC - ADR ADAP from Outperform to Market Perform. Adaptimmune Therapeutics shares fell 5 percent to $4.15 in pre-market trading.
  • BMO Capital downgraded Physicians Realty Trust DOC from Outperform to Market Perform. Physicians Realty shares fell 4.2 percent to $17.45 in pre-market trading.

 

Top Initiations

  • Analysts at Stifel initiated coverage on Jumia Technologies AG - ADR JMIA with a Hold rating. Jumia Technologies closed at $37.72 on Monday.
  • Nomura initiated coverage on Texas Instruments Incorporated TXN with a Neutral rating. . The price target for Texas Instruments is set to $106. Texas Instruments shares closed at $115.86 on Monday.
  • Stephens & Co. initiated coverage on Roku Inc ROKU with an Overweight rating. The price target for Roku is set to $84. Roku shares closed at $65.75 on Monday.
  • 86 Research initiated coverage on Pinduoduo Inc PDD with a Hold rating. Pinduoduo shares closed at $23.74 on Monday.
  • Analysts at B. Riley initiated coverage on Cumulus Media Inc CMLS with a Neutral rating. The price target for Cumulus Media is set to $20. Cumulus Media shares closed at $17.90 on Monday.
  • Bernstein initiated coverage on Beyond Meat Inc BYND with an Outperform rating. Beyond Meat shares closed at $74.79 on Monday.
  • Raymond James initiated coverage on Jumia Technologies AG - ADR JMIA with a Market Perform rating. Jumia Technologies closed at $37.72 on Monday.
  • H.C. Wainwright initiated coverage on Coherus Biosciences Inc CHRS with a Buy rating. The price target for Coherus Biosciences is set to $28. Coherus Biosciences shares closed at $16.71 on Monday.

Posted In: Iniiationstop upgradesUpgradesDowngradesInitiationPre-Market OutlookAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.